Ophthalmology Doctors in Las Cruces, NM Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Dr. Robert L Villalobos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2030 S Solano Dr, Las Cruces, NM 88001 Phone: 505-521-1158    Fax: 505-521-1007

Dr. Edward Victor Hernandez, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2810 N Telshor Blvd, Las Cruces, NM 88011 Phone: 575-523-2020    Fax: 575-521-1553

Eric Weber, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2030 S Solano Dr, Las Cruces, NM 88001 Phone: 575-521-1158    Fax: 575-521-1007

Mr. Richard W Lazaro, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1505 S Don Roser Dr Ste A, Las Cruces, NM 88011 Phone: 575-522-7676    Fax: 575-522-8121

Dr. Ryan B Anderson, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2030 S Solano Dr, Las Cruces, NM 88001 Phone: 575-521-1158    Fax: 575-521-1007

Charles Louis Schaffer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2030 S Solano Dr, Las Cruces, NM 88001 Phone: 575-521-1158

Jon Roger Hall, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 755 S Telshor Blvd, Ste 101c, Las Cruces, NM 88011 Phone: 575-522-3393

News Archive

Antihistamine drugs work by preventing histamine from attaching to H1 receptors

Itchy eyes, scratchy throat, running nose-it's allergy season! What triggers these allergic reactions, and how do allergy medications work?

OphthaliX updates website to reflect proposed acquisition of Israel-based Improved Vision Systems

OphthaliX Inc., a clinical-stage company focused on developing products that treat and improve sight for people living with ophthalmic disorders, and a subsidiary of Can-Fite BioPharma Ltd., announced today it has launched an updated website, www.ophthaliX.com, to reflect its definitive agreement to acquire Israel-based Improved Vision Systems Ltd.

Men treated with hormone-based therapy for prostate cancer face higher risk of colorectal cancer: Study

Men treated with hormone-based therapy for prostate cancer faced a 30 percent to 40 percent higher risk of colorectal cancer, compared to patients who did not receive this treatment, according to a new study.

Novela Neurotech joins hands with UCSF to break down neurodata borders

Just as computer scientists developed standards to deliver digital content across the globe to your laptop, neuroscientists are working to break down barriers in data sharing.

Rutgers experts highlight increase in suicide attempts among preteens, mainly girls

Since January 2018, 100 New Jersey preteens have attempted suicide by drug overdose, according to data released by the New Jersey Poison Center.

Read more Medical News

› Verified 8 days ago